Recent preclinical studies have found that the reactivation of p53 consequent to inhibition of the MDM2-p53 interaction or XPO1 (a nuclear exporter for p53) via non-genotoxic small molecule inhibitors can induce apoptosis in lymphoma cells [9–11]. The gene discussed is XPO1; the disease is lymphoma.